Astelin Pediatric Dosing
For children aged 6-11 years with seasonal allergic rhinitis, Astelin (azelastine 0.1%) nasal spray is dosed as 1 spray per nostril twice daily. For adolescents 12 years and older, the dose is 1-2 sprays per nostril twice daily 1.
Age-Specific Dosing Guidelines
Children 5-11 Years
- Seasonal Allergic Rhinitis: 1 spray per nostril twice daily (0.56 mg/day total) 1, 2
- This is the FDA-approved dosing for Astelin 0.1% solution (137 µg per spray)
- No FDA approval for vasomotor rhinitis in this age group
Adolescents ≥12 Years
- Seasonal Allergic Rhinitis: 1-2 sprays per nostril twice daily OR 2 sprays once daily 2
- Vasomotor Rhinitis: 2 sprays per nostril twice daily 1
- Greater dosing flexibility allows for symptom-based adjustment
Important Clinical Considerations
Proper administration technique is critical to minimize the most common side effect—bitter taste—which occurs in approximately 19.7% of patients but can be reduced with correct technique 3. Instruct patients to:
- Keep head tilted downward (not back) when spraying to avoid medication draining into throat
- Prime pump with 4 sprays before initial use, or 2 sprays if ≥3 days have elapsed since last use 1
- Alternate nostrils between sprays
- Breathe gently after administration
Somnolence rates are low in pediatric populations. While early studies reported rates around 11%, more recent data shows 0.4-3%, comparable to placebo 2. However, caution patients about potential drowsiness at treatment initiation and schedule follow-up to assess response 2.
Efficacy in Pediatric Populations
Azelastine demonstrates rapid onset of action within 15-30 minutes 3, 4, making it particularly useful for episodic symptoms or pre-exposure prophylaxis before allergen contact 2. The intranasal antihistamine shows superiority over oral antihistamines specifically for nasal congestion 2.
Recent high-quality evidence in children aged 6-11 years with perennial allergic rhinitis demonstrated that azelastine 0.15% achieved a 20.2% reduction in reflective total nasal symptom scores over 28 days, with excellent tolerability (only 1 patient reporting mild somnolence) 5. This 2025 study represents the most recent pediatric data available.
Common Pitfalls to Avoid
- Incorrect head position: Tilting head backward causes medication to drain into throat, resulting in bitter taste and reduced efficacy
- Inadequate priming: Failure to prime properly may deliver medication as a stream rather than fine mist, reducing effectiveness
- Discontinuation due to taste: Consider switching to azelastine 0.15% formulation (Astepro), which contains sorbitol and sucralose to improve taste 2
- Age restrictions: Astelin is not FDA-approved for children under 5 years of age
Safety Profile
Adverse events are generally mild and include bitter taste, epistaxis, headache, and somnolence 2. The medication has been used safely in pediatric populations for decades with extensive postmarketing surveillance data showing 90% of patients report no adverse events 6. No contraindications exist beyond hypersensitivity to components 2.